Ana Sofia Ferreira

Articles by Ana Sofia Ferreira

TPS 24 Phase Ib Dose-Finding Study of [177Lu]Lu-NeoB + Ribociclib + Fulvestrant in Patients With ER+/HER2− Advanced Breast Cancer With GRPR Expression With Early Relapse FromAdjuvant Endocrine Therapy or Progression on ET + CDK4/6i for ABC

ByDebasish Tripathy,Dejan Juric,Sonia Pernas,Francois Clement Bidard,Kevin Perraud,Louise Emmett,Ana Sofia Ferreira

June 22nd 2025

Latest Updated Articles

TPS 24 Phase Ib Dose-Finding Study of [177Lu]Lu-NeoB + Ribociclib + Fulvestrant in Patients With ER+/HER2− Advanced Breast Cancer With GRPR Expression With Early Relapse FromAdjuvant Endocrine Therapy or Progression on ET + CDK4/6i for ABC
June 22nd 2025

Trending on CancerNetwork

Key Takeaways for Multidisciplinary Lung Cancer Care From WCLC 2026

Pembrolizumab/Enfortumab Vedotin Earns Positive CHMP Opinion in MIBC

FDA Approves Imlunestrant Combo in ESR1-Mutated Breast Cancer

NCCN Guidelines Strengthen MRD Testing Recommendations in Multiple Myeloma

CELMoDs After T-Cell–Engaging Therapy in Multiple Myeloma